(Q34555213)

3 August 2017

1 reference

title

How does studying schizotypal personality disorder inform us about the prodrome of schizophrenia? (English)

1 reference

schizotypal personality disorder

3 August 2017

0 references

1 reference

2

Kristin S Cadenhead

1 reference

3 August 2017

Katherine Seeber

1

1 reference

PubMed ID

15717986

3 August 2017

language of work or name

English

0 references

publication date

1 March 2005

1 reference

Current Psychiatry Reports

3 August 2017

1 reference

3 August 2017

7

1 reference

3 August 2017

1

1 reference

3 August 2017

41-50

1 reference

https://scigraph.springernature.com/pub.10.1007/s11920-005-0024-5

3 August 2017

0 references

cites work

Prodromal assessment with the structured interview for prodromal syndromes and the scale of prodromal symptoms: predictive validity, interrater reliability, and training to reliability

1 reference

https://api.crossref.org/works/10.1007%2FS11920-005-0024-5

Clinical variables and genetic loading for schizophrenia: analysis of published Danish adoption study data

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-005-0024-5

Using neurophysiological markers of genetic risk to define the boundaries of the schizophrenia spectrum phenotype.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-005-0024-5

Neurocognitive deficits and functional outcome in schizophrenia: are we measuring the "right stuff"?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-005-0024-5

A review and new report of medial temporal lobe dysfunction as a vulnerability indicator for schizophrenia: a magnetic resonance imaging morphometric family study of the parahippocampal gyrus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-005-0024-5

Neuromotor functioning in adolescents with schizotypal personality disorder: associations with symptoms and neurocognition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11920-005-0024-5

P50 sensory gating in adolescents from a pacific island isolate with elevated risk for schizophrenia

21 January 2018

1 reference

12 December 2020

Diagnosing schizophrenia in the initial prodromal phase

1 reference

12 December 2020

The schizophrenia prodrome: treatment and high-risk perspectives.

1 reference

12 December 2020

Ethics and early intervention in psychosis: keeping up the pace and staying in step

1 reference

12 December 2020

Efficacy and tolerability of olanzapine in the treatment of schizotypal personality disorder

1 reference

12 December 2020

Randomized trial of olanzapine versus placebo in the symptomatic acute treatment of the schizophrenic prodrome

1 reference

12 December 2020

Spatial working memory ability is a marker of risk-for-psychosis.

1 reference

12 December 2020

Body-image aberration in Schizophrenia

1 reference

12 December 2020

Defining the schizophrenia phenotype

1 reference

12 December 2020

Effects of acute metabolic stress on the dopaminergic and pituitary-adrenal axis activity in patients with schizotypal personality disorder.

1 reference

12 December 2020

Reduced processing resource availability in schizotypal personality disorder: evidence from a dual-task CPT study.

1 reference

12 December 2020

Treatment of the schizophrenia prodrome: is it presently ethical?

1 reference

12 December 2020

Prediction and prevention of transition to psychosis in young people at incipient risk for schizophrenia

1 reference

12 December 2020

Risk factors for psychosis in an ultra high-risk group: psychopathology and clinical features

1 reference

12 December 2020

Genetic risk of neuropsychological impairment in schizophrenia: a study of monozygotic twins discordant and concordant for the disorder.

1 reference

12 December 2020

Randomized controlled trial of interventions designed to reduce the risk of progression to first-episode psychosis in a clinical sample with subthreshold symptoms

1 reference

12 December 2020

Subjective and objective neuropsychological abnormalities in a psychosis prodrome clinic.

1 reference

12 December 2020

Relationship between positive and negative symptoms of schizophrenia and schizotypal symptoms in nonpsychotic relatives

1 reference

12 December 2020

An integration of schizophrenia with schizotypy: identification of schizotaxia and implications for research on treatment and prevention

1 reference

12 December 2020

Neurobiological measures of schizotypal personality disorder: defining an inhibitory endophenotype?

1 reference

12 December 2020

Cognitive function and biological correlates of cognitive performance in schizotypal personality disorder

1 reference

12 December 2020

Prospective diagnosis of the initial prodrome for schizophrenia based on the Structured Interview for Prodromal Syndromes: preliminary evidence of interrater reliability and predictive validity

1 reference

12 December 2020

Psychological treatment in pre- and early psychosis

1 reference

12 December 2020

Neuropsychological status of subjects at high risk for a first episode of psychosis

1 reference

12 December 2020

Neuropsychological profile in patients with schizotypal personality disorder or schizophrenia.

1 reference

12 December 2020

Early detection and intervention in first-episode schizophrenia: a critical review

1 reference

12 December 2020

Association between nonpsychotic psychiatric diagnoses in adolescent males and subsequent onset of schizophrenia

1 reference

12 December 2020

The genetic relationship of personality to major depression and schizophrenia

1 reference

12 December 2020

Risperidone in the treatment of schizotypal personality disorder.

1 reference

12 December 2020

Nonspecific and attenuated negative symptoms in patients at clinical high-risk for schizophrenia

1 reference

12 December 2020

Positron emission tomography: imaging and quantification of neurotransporter availability

1 reference

12 December 2020

Risk factors for transition to first episode psychosis among individuals with 'at-risk mental states'.

1 reference

12 December 2020

Striatal amphetamine-induced dopamine release in patients with schizotypal personality disorder studied with single photon emission computed tomography and [123I]iodobenzamide

1 reference

12 December 2020

Academic deterioration prior to first episode schizophrenia in young Singaporean males.

1 reference

12 December 2020

Impaired olfactory identification in relatives of patients with familial schizophrenia.

1 reference

12 December 2020

Shape of caudate nucleus and its cognitive correlates in neuroleptic-naive schizotypal personality disorder

1 reference

12 December 2020

Early detection and secondary prevention of psychosis: facts and visions

1 reference

12 December 2020

Processing sentence context in women with schizotypal personality disorder: an ERP study

1 reference

12 December 2020

Striatal size and relative glucose metabolic rate in schizotypal personality disorder and schizophrenia

1 reference

12 December 2020

Evaluating and treating the prodromal stage of schizophrenia

1 reference

12 December 2020

Voxel-based morphometry of grey matter densities in subjects at high risk of schizophrenia.

1 reference

12 December 2020

Generalized cognitive impairment in male adolescents with schizotypal personality disorder

1 reference

12 December 2020

Scent of a disorder: olfactory functioning in schizophrenia

1 reference

12 December 2020

A MRI study of fusiform gyrus in schizotypal personality disorder

1 reference

12 December 2020

The New York high risk project to the Hillside recognition and prevention (RAP) program

1 reference

12 December 2020

Vulnerability markers in the schizophrenia spectrum: implications for phenomenology, genetics, and the identification of the schizophrenia prodrome

1 reference

12 December 2020

The pathophysiology of schizophrenia disorders: perspectives from the spectrum

1 reference

12 December 2020

Impairment of Olfactory Identification Ability in Individuals at Ultra-High Risk for Psychosis Who Later Develop Schizophrenia

1 reference

12 December 2020

Incipient neurovulnerability and neuroprotection in early psychosis

1 reference

12 December 2020

10.1007/S11920-005-0024-5

Identifiers

DOI

1 reference

PubMed ID

15717986

Dimensions Publication ID

3 August 2017

0 references

1 reference

PubMed ID

15717986